MoneyWorks4Me

Mercury Laboratories - Quaterly Results

05 Aug 2023 Evaluate
A minor change in the total revenue was seen in the June 2023 quarter. The total revenue for the quarter stood at Rs. 183.22 millions against Rs. 175.99 millions during year ago period.The Net Profit of the company slipped to Rs. 10.00 millions from Rs. 14.63 millions, a decline of -31.65% on QoQ basis.A decline of 18.06 millions was observed in the OP in the quarter ended June 2023 from 27.60 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 183.22 175.99 4.11 183.22 175.99 4.11 753.34 579.24 30.06
Other Income 1.45 4.92 -70.53 1.45 4.92 -70.53 17.19 8.16 110.66
PBIDT 18.06 27.60 -34.57 18.06 27.60 -34.57 102.90 78.06 31.82
Interest 0.75 0.94 -20.21 0.75 0.94 -20.21 3.62 4.46 -18.83
PBDT 17.31 26.66 -35.07 17.31 26.66 -35.07 99.76 74.88 33.23
Depreciation 6.75 6.15 9.76 6.75 6.15 9.76 24.83 24.53 1.22
PBT 10.56 20.51 -48.51 10.56 20.51 -48.51 74.93 50.35 48.82
TAX 0.56 5.88 -90.48 0.56 5.88 -90.48 19.14 14.73 29.94
Deferred Tax -2.94 -0.93 216.13 -2.94 -0.93 216.13 -3.38 1.02 -431.37
PAT 10.00 14.63 -31.65 10.00 14.63 -31.65 55.79 35.62 56.63
Equity 12.00 12.00 0.00 12.00 12.00 0.00 12.00 12.00 0.00
PBIDTM(%) 9.86 15.68 -37.15 9.86 15.68 -37.15 13.66 13.48 1.36
Peers
Company Name CMP
Sun Pharma. Inds. 1841.50
Dr. Reddys Labs. 1243.65
Cipla 1386.75
Lupin 2083.15
Zydus Lifesciences 1213.55
View more..